FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894764274> ?p ?o ?g. }

• W2894764274 endingPage "292" @default.
• W2894764274 startingPage "285" @default.
• W2894764274 abstract "Medication adverse events are important and common yet are often not identified by clinicians. We evaluated an automated telephone surveillance system coupled with transfer to a live pharmacist to screen potentially drug-related symptoms after newly starting medications for four common primary care conditions: hypertension, diabetes, depression, and insomnia. Cluster randomized trial with automated calls to eligible patients at 1 and 4 months after starting target drugs from intervention primary care clinics compared to propensity-matched patients from control clinics. Primary and secondary outcomes were physician documentation of any adverse effects associated with newly prescribed target medication, and whether the medication was discontinued and, if yes, whether the reason for stopping was an adverse effect. Of 4876 eligible intervention clinic patients who were contacted using automated calls, 776 (15.1%) responded and participated in the automated call. Based on positive symptom responses or request to speak to a pharmacist, 320 patients were transferred to the pharmacist and discussed 1021 potentially drug-related symptoms. Of these, 188 (18.5%) were assessed as probably and 479 (47.1%) as possibly related to the medication. Compared to a propensity-matched cohort of control clinic patients, intervention patients were significantly more likely to have adverse effects documented in the medical record by a physician (277 vs. 164 adverse effects, p < 0.0001, and 177 vs. 122 patients discontinued with documented adverse effects, p < 0.0001). Systematic automated telephone outreach monitoring coupled with real-time phone referral to a pharmacist identified a substantial number of previously unidentified potentially drug-related symptoms, many of which were validated as probably or possibly related to the drug by the pharmacist or their physicians. Multiple challenges were encountered using the interactive voice response (IVR) automated calling system, suggesting that other approaches may need to be considered and evaluated. ClinicalTrials.gov : NCT02087293" @default.
• W2894764274 created "2018-10-12" @default.
• W2894764274 creator A5020737811 @default.
• W2894764274 creator A5024320373 @default.
• W2894764274 creator A5033742702 @default.
• W2894764274 creator A5036110536 @default.
• W2894764274 creator A5040486560 @default.
• W2894764274 creator A5042433127 @default.
• W2894764274 creator A5042948275 @default.
• W2894764274 creator A5047513111 @default.
• W2894764274 creator A5055661680 @default.
• W2894764274 creator A5059946874 @default.
• W2894764274 creator A5068708746 @default.
• W2894764274 creator A5072267971 @default.
• W2894764274 creator A5077742389 @default.
• W2894764274 date "2018-10-05" @default.
• W2894764274 modified "2023-09-23" @default.
• W2894764274 title "Screening for Adverse Drug Events: a Randomized Trial of Automated Calls Coupled with Phone-Based Pharmacist Counseling" @default.
• W2894764274 cites W1227784392 @default.
• W2894764274 cites W1779924585 @default.
• W2894764274 cites W1966286696 @default.
• W2894764274 cites W1967503797 @default.
• W2894764274 cites W1971020009 @default.
• W2894764274 cites W1999676312 @default.
• W2894764274 cites W2022909531 @default.
• W2894764274 cites W2060706173 @default.
• W2894764274 cites W2094450723 @default.
• W2894764274 cites W2096721022 @default.
• W2894764274 cites W2097379719 @default.
• W2894764274 cites W2098699324 @default.
• W2894764274 cites W2104973603 @default.
• W2894764274 cites W2126442448 @default.
• W2894764274 cites W2128043538 @default.
• W2894764274 cites W2161554615 @default.
• W2894764274 cites W2166478362 @default.
• W2894764274 cites W2169806496 @default.
• W2894764274 cites W2272376925 @default.
• W2894764274 cites W2320319041 @default.
• W2894764274 cites W2345161095 @default.
• W2894764274 cites W2399143343 @default.
• W2894764274 cites W2551817902 @default.
• W2894764274 cites W2609971864 @default.
• W2894764274 cites W34638141 @default.
• W2894764274 cites W56637561 @default.
• W2894764274 doi "https://doi.org/10.1007/s11606-018-4672-7" @default.
• W2894764274 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6374268" @default.
• W2894764274 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30291602" @default.
• W2894764274 hasPublicationYear "2018" @default.
• W2894764274 type Work @default.
• W2894764274 sameAs 2894764274 @default.
• W2894764274 citedByCount "8" @default.
• W2894764274 countsByYear W28947642742021 @default.
• W2894764274 countsByYear W28947642742022 @default.
• W2894764274 countsByYear W28947642742023 @default.
• W2894764274 crossrefType "journal-article" @default.
• W2894764274 hasAuthorship W2894764274A5020737811 @default.
• W2894764274 hasAuthorship W2894764274A5024320373 @default.
• W2894764274 hasAuthorship W2894764274A5033742702 @default.
• W2894764274 hasAuthorship W2894764274A5036110536 @default.
• W2894764274 hasAuthorship W2894764274A5040486560 @default.
• W2894764274 hasAuthorship W2894764274A5042433127 @default.
• W2894764274 hasAuthorship W2894764274A5042948275 @default.
• W2894764274 hasAuthorship W2894764274A5047513111 @default.
• W2894764274 hasAuthorship W2894764274A5055661680 @default.
• W2894764274 hasAuthorship W2894764274A5059946874 @default.
• W2894764274 hasAuthorship W2894764274A5068708746 @default.
• W2894764274 hasAuthorship W2894764274A5072267971 @default.
• W2894764274 hasAuthorship W2894764274A5077742389 @default.
• W2894764274 hasBestOaLocation W28947642741 @default.
• W2894764274 hasConcept C104863432 @default.
• W2894764274 hasConcept C126322002 @default.
• W2894764274 hasConcept C168563851 @default.
• W2894764274 hasConcept C194828623 @default.
• W2894764274 hasConcept C197934379 @default.
• W2894764274 hasConcept C2776135927 @default.
• W2894764274 hasConcept C2779457091 @default.
• W2894764274 hasConcept C512399662 @default.
• W2894764274 hasConcept C71924100 @default.
• W2894764274 hasConceptScore W2894764274C104863432 @default.
• W2894764274 hasConceptScore W2894764274C126322002 @default.
• W2894764274 hasConceptScore W2894764274C168563851 @default.
• W2894764274 hasConceptScore W2894764274C194828623 @default.
• W2894764274 hasConceptScore W2894764274C197934379 @default.
• W2894764274 hasConceptScore W2894764274C2776135927 @default.
• W2894764274 hasConceptScore W2894764274C2779457091 @default.
• W2894764274 hasConceptScore W2894764274C512399662 @default.
• W2894764274 hasConceptScore W2894764274C71924100 @default.
• W2894764274 hasIssue "2" @default.
• W2894764274 hasLocation W28947642741 @default.
• W2894764274 hasLocation W28947642742 @default.
• W2894764274 hasLocation W28947642743 @default.
• W2894764274 hasLocation W28947642744 @default.
• W2894764274 hasOpenAccess W2894764274 @default.
• W2894764274 hasPrimaryLocation W28947642741 @default.
• W2894764274 hasRelatedWork W1770214944 @default.
• W2894764274 hasRelatedWork W2042489430 @default.
• W2894764274 hasRelatedWork W2053221007 @default.
• W2894764274 hasRelatedWork W2139101108 @default.

• next